The development of low-dose IL-2 therapy for inflammatory and autoimmune diseases

The development of low-dose IL-2 therapy for inflammatory and autoimmune diseases

Updated:  23 August 2017/Responsible Officer:  Director, JCSMR/Page Contact:  Web Manager